Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 12 studies | 25% ± 9% | |
amacrine cell | 5 studies | 28% ± 8% | |
mesothelial cell | 4 studies | 21% ± 4% | |
GABAergic neuron | 4 studies | 34% ± 17% | |
renal principal cell | 4 studies | 43% ± 15% | |
GABAergic amacrine cell | 3 studies | 25% ± 6% | |
glutamatergic neuron | 3 studies | 31% ± 9% | |
connective tissue cell | 3 studies | 25% ± 1% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 28% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 93% | 574.02 | 1351 / 1445 | 89% | 5.29 | 163 / 183 |
kidney | 100% | 1372.35 | 89 / 89 | 55% | 3.49 | 492 / 901 |
lung | 97% | 795.71 | 562 / 578 | 53% | 1.97 | 609 / 1155 |
thymus | 94% | 470.51 | 617 / 653 | 47% | 1.27 | 282 / 605 |
stomach | 79% | 295.54 | 282 / 359 | 60% | 2.33 | 171 / 286 |
intestine | 96% | 610.17 | 924 / 966 | 39% | 1.48 | 208 / 527 |
breast | 93% | 336.25 | 428 / 459 | 41% | 0.93 | 455 / 1118 |
uterus | 99% | 1077.52 | 169 / 170 | 25% | 1.04 | 115 / 459 |
adrenal gland | 93% | 609.48 | 240 / 258 | 29% | 2.12 | 67 / 230 |
bladder | 81% | 721.90 | 17 / 21 | 29% | 0.98 | 146 / 504 |
prostate | 94% | 480.51 | 231 / 245 | 11% | 0.20 | 56 / 502 |
skin | 90% | 4364.59 | 1635 / 1809 | 13% | 0.79 | 63 / 472 |
ovary | 92% | 366.02 | 165 / 180 | 11% | 0.24 | 49 / 430 |
pancreas | 30% | 94.41 | 97 / 328 | 70% | 2.31 | 124 / 178 |
blood vessel | 98% | 661.33 | 1311 / 1335 | 0% | 0 | 0 / 0 |
adipose | 98% | 955.15 | 1181 / 1204 | 0% | 0 | 0 / 0 |
heart | 78% | 498.95 | 672 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 47% | 1.59 | 21 / 45 |
brain | 5% | 12.24 | 131 / 2642 | 23% | 0.60 | 163 / 705 |
muscle | 19% | 36.38 | 153 / 803 | 0% | 0 | 0 / 0 |
liver | 8% | 23.60 | 18 / 226 | 7% | 0.14 | 28 / 406 |
lymph node | 0% | 0 | 0 / 0 | 10% | 0.20 | 3 / 29 |
spleen | 8% | 17.37 | 19 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0.48 | 3 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0071548 | Biological process | response to dexamethasone |
GO_0019538 | Biological process | protein metabolic process |
GO_0032354 | Biological process | response to follicle-stimulating hormone |
GO_0006508 | Biological process | proteolysis |
GO_0007565 | Biological process | female pregnancy |
GO_0030163 | Biological process | protein catabolic process |
GO_0007166 | Biological process | cell surface receptor signaling pathway |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0004222 | Molecular function | metalloendopeptidase activity |
GO_0005515 | Molecular function | protein binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0008237 | Molecular function | metallopeptidase activity |
Gene name | PAPPA |
Protein name | Pregnacy-associated plasma protein A Pappalysin-1 (EC 3.4.24.79) (Insulin-like growth factor-dependent IGF-binding protein 4 protease) (IGF-dependent IGFBP-4 protease) (IGFBP-4ase) (Pregnancy-associated plasma protein A) (PAPP-A) |
Synonyms | |
Description | FUNCTION: Metalloproteinase which specifically cleaves IGFBP-4 and IGFBP-5, resulting in release of bound IGF. Cleavage of IGFBP-4 is dramatically enhanced by the presence of IGF, whereas cleavage of IGFBP-5 is slightly inhibited by the presence of IGF. . |
Accessions | Q5QFB7 ENST00000328252.4 Q13219 |